Biorevitalizing peels based on TCA (trichloroacetic acid) have long been used in aesthetic medicine to stimulate skin renewal through a controlled chemical injury. This approach can offer visible results in the short term, but presents biological criticalities that deserve deeper reflection, especially with regard to long-term skin health.
An effective but non-physiological mechanism
TCA acts through irreversible protein denaturation, with coagulation of superficial epidermal and dermal proteins. This is a non-selective process that induces a strong inflammatory response, increasing oxidative stress and pro-inflammatory mediators. If repeated over time, it can compromise the barrier function and accelerate inflamm-aging processes.
High concentrations and chemical compensations
Many biorevitalizing peels on the market use high percentages of TCA (33%-35%), obviously buffered with substances like ammonia or equivalents plus strong oxidative agents. These compensations, although reducing immediate aggressiveness, create a biologically stressful skin environment, with disorganization of the extracellular matrix and chronic fibroblast distress.
Skin Longevity: a paradigm shift
The concept of Skin Longevity shifts the focus from immediate effect to preservation of the skin’s biological capital. The goal is no longer to provoke a forced reaction, but to stimulate a physiological, progressive, and sustainable response.
The MEDEA approach
Within this vision is 3PH ExoPeel, a system that avoids chemical necrosis and toxic compensations, promoting a controlled biological activation. Thanks to a multiphase technology and advanced biotechnological actives, it supports regeneration and turnover in full respect of skin physiology.
Rethinking the peel
Today, peeling should not be an aggressive act, but a conscious act of care. An approach oriented towards Skin Longevity allows for real results, protecting the skin over time and building a healthier, longer-lasting, and more resilient beauty.
